Do you have concerns with the use of oral contraceptives in patients on JAK inhibitors given the black box warning for thromboembolic events?
How has this impacted your counseling and management?
Answer from: at Academic Institution
I would be concerned with the use of estrogen-containing OC especially in patients who are smokers, obese, and/or with a strong family history of CV disease. However, I know many rheumatologists who would still cautiously prescribe JAK inhibitors to these patients, particularly in the absence of add...
Sign in or Register to read more
Answer from: at Community Practice
Taking estrogen-containing OCPs alone while on JAKI treatment doesn't appear to increase thromboembolic events.
Comments
at Uniformed Services University of the Health Sciences (USUHS)
Especially when it is a solitary risk factor, I to...
Especially when it is a solitary risk factor, I to...